Results 281 to 290 of about 86,953 (307)

[Control of graft-vs-host disease].

[Rinsho ketsueki] The Japanese journal of clinical hematology, 1990
Considering the merit and demerit of GVHD in leukemia patients following allogeneic BMT, our strategies for GVHD are as follows; (1) a mild prevention, (2) a treatment to control the severity, if occurred, and (3) an induction of GVHD in recipients who did not develop GVHD. We reported the results of recent trials in prevention, treatment and induction
openaire   +1 more source

GRAFT REJECTION AND GRAFT-VERSUS-HOST DISEASE: MIRROR IMAGES

Lancet, The, 1986
Yair Y Reisner
exaly  

Endothelial injury mediated by cytotoxic T lymphocytes and loss of microvessels in chronic graft versus host disease

Lancet, The, 2002
Jordan S Pober
exaly  

Lichen Planus and Graft-vs.-Host Disease

2004
de Vries, H. J. C., Tank, B., Hoekzema, R.   +2 more
openaire   +3 more sources

Acute graft-versus-host disease of the gut: considerations for the gastroenterologist

Nature Reviews Gastroenterology and Hepatology, 2017
Huaibin Mabel Ko, John E Levine, James L M Ferrara   +2 more
exaly  

Effect of graft-versus-host disease prophylaxis on 3-year disease-free survival in recipients of unrelated donor bone marrow (T-cell Depletion Trial): a multi-centre, randomised phase II–III trial

Lancet, The, 2005
Nancy A Kernan
exaly  

Relief for Graft-vs-Host Disease

JAMA, 2017
openaire   +2 more sources

Eczematoid Graft-vs-Host Disease

Archives of Dermatology, 2008
openaire   +1 more source

ELIMINATION OF GRAFT-VERSUS-HOST DISEASE BY IN-VITRO DEPLETION OF ALLOREACTIVE LYMPHOCYTES WITH A MONOCLONAL RAT ANTI-HUMAN LYMPHOCYTE ANTIBODY (CAMPATH-1)

Lancet, The, 1984
Geoff Hale
exaly  

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

Lancet, The, 2008
Katarina Le Blanc, Francesco Frassoni, Franco Locatelli   +2 more
exaly